Improving transition from paediatric to adult cystic fibrosis care: programme implementation and evaluation

Megumi J Okumura1, Thida Ong, Diana Dawson

  • 1Division of General Pediatrics, University of California, , San Francisco, California, USA.

BMJ Quality & Safety
|January 14, 2014
PubMed

Insights

A new quality improvement program successfully transitioned pediatric cystic fibrosis (CF) patients to adult care, enhancing communication and readiness. This initiative improved patient self-advocacy and reduced hospital transfers, optimizing CF care transitions.

Area of Science:

  • Medical Sciences
  • Healthcare Quality Improvement
  • Patient Transition Care

Background:

  • Effective therapies are extending the lives of cystic fibrosis (CF) patients into adulthood.
  • High-quality care during the transition from pediatric to adult CF centers is crucial for survival.
  • This transfer process presents significant challenges for patients and healthcare providers.

Purpose of the Study:

  • To develop, implement, and evaluate a theory-based program for transitioning pediatric CF patients to adult care.
  • To create a standardized curriculum, care standards, and patient transfer protocols.
  • To assess the impact of the transition program on patient readiness and healthcare processes.

Main Methods:

  • A multi-phase quality improvement project involving collaboration between pediatric and adult CF teams.
  • Development of a transition curriculum and standardized transfer protocols.
  • Evaluation using staff surveys, meeting notes, transfer tracking, and the Transition Readiness Assessment Questionnaire (TRAQ).

Main Results:

  • Sustained collaboration through quarterly meetings over 4 years.
  • A significant increase in transition discussions with families (35% to 73%, p<0.001).
  • A trend towards improved patient self-advocacy scores on the TRAQ and decreased in-hospital transfers.

Conclusions:

  • A successful curriculum and process for transitioning pediatric to adult CF care were established.
  • The collaboration enhanced communication among CF care teams and facilitated feedback loops.
  • Future evaluation is needed to determine the long-term impact on patient morbidity.
Abstract

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
657
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
1.1K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
410
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
631
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
563
Chronic Obstructive Pulmonary Disease-V: Nursing Management01:30

Chronic Obstructive Pulmonary Disease-V: Nursing Management

Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
5.4K